JPH06343419A - Antiobestic food - Google Patents

Antiobestic food

Info

Publication number
JPH06343419A
JPH06343419A JP5164024A JP16402493A JPH06343419A JP H06343419 A JPH06343419 A JP H06343419A JP 5164024 A JP5164024 A JP 5164024A JP 16402493 A JP16402493 A JP 16402493A JP H06343419 A JPH06343419 A JP H06343419A
Authority
JP
Japan
Prior art keywords
weight
cyclodextrin
parts
food
linolenic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5164024A
Other languages
Japanese (ja)
Other versions
JP2510943B2 (en
Inventor
Masakazu Matsushima
正和 松島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DR MAINTSU KK
Maintsu Kk Dr
Original Assignee
DR MAINTSU KK
Maintsu Kk Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DR MAINTSU KK, Maintsu Kk Dr filed Critical DR MAINTSU KK
Priority to JP5164024A priority Critical patent/JP2510943B2/en
Publication of JPH06343419A publication Critical patent/JPH06343419A/en
Application granted granted Critical
Publication of JP2510943B2 publication Critical patent/JP2510943B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE:To obtain an antiobestic food exerting excellent preventive effect on obesity or weight gain by the synergism of alpha-cyclodextrin and gamma-linolenic acid by compounding a cyclodextrin, gamma-linolenic acid and saponin. CONSTITUTION:This antiobestic food is obtained by compounding 100 pts.wt. of alpha-cyclodextrin with 0.5-10 pts.wt. of gamma-linolenic acid, 0.3-6 pts.wt. of saponin and further optionally 0-5 pts.wt. of chlorophyll, TOTYUUYOU (leaf of Euonymus tricocarpus) extract, lactobacillus sporogenes or one or more than two kinds of active peptides. The antiobestic food is capable of exerting extremely excellent preventive effect on obesity or weight gain by the synergism of alpha-cyclodextrin and gamma-linolenic acid.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は痩身用食品に関する。FIELD OF THE INVENTION The present invention relates to a slimming food.

【0002】[0002]

【従来の技術】サイクロデキストリンにはα−サイクロ
デキストリン、β−サイクロデキストリン並びにγ−サ
イクロデキストリンの3種の化合物が存在する。これ等
サイクロデキストリンは古くから食品用の素材として使
用されて来ている。
Cyclodextrins include three types of compounds, α-cyclodextrin, β-cyclodextrin and γ-cyclodextrin. These cyclodextrins have been used as materials for food since ancient times.

【0003】そして最近サイクロデキストリンの1種た
るα−サイクロデキストリンは、痩身用食品の素材とし
て使用出来る可能性のあることが発表された。
It has recently been announced that α-cyclodextrin, which is one of cyclodextrins, may be used as a material for slimming foods.

【0004】一方γ−リノレン酸は脂肪代謝作用を有す
る物質として知られており、健康維持に好適な物質とし
て知られている。
On the other hand, γ-linolenic acid is known as a substance having a fat metabolism action, and is known as a substance suitable for maintaining health.

【0005】また、α−サイクロデキストリンとγ−リ
ノレン酸とを併用することにより、その相乗作用により
著しく優れた肥満乃至体重増加防止効果を発揮すること
を基本とする痩身用食品が開発されている(特公昭62
−44905号)。
Further, a slimming food has been developed which is based on the combined use of α-cyclodextrin and γ-linolenic acid to exert a remarkably excellent effect of preventing obesity or weight gain due to their synergistic effect. (Japanese Patent Publication Sho 62
-44905).

【0006】本発明者は、従来から痩身用食品について
研究を続け、特にα−サイクロデキストリンとγ−リノ
レン酸とから成る痩身用食品について研究を続けて来
た。この研究に於いて、これ等上記2種の成分に更に第
三成分を添加することにより、更に優れた痩身用効果が
得られるかもしれないとの新しい着想に至った。
The inventor of the present invention has been continuing research on slimming foods, and particularly on slimming foods composed of α-cyclodextrin and γ-linolenic acid. In this research, a new idea that a more excellent slimming effect may be obtained by adding a third component to the above two components has been reached.

【0007】[0007]

【発明が解決しようとする課題】従って本発明が解決し
ようとする課題はα−サイクロデキストリンとγ−リノ
レン酸とを主成分としてなる痩身用食品に、更に一段と
優れた痩身作用を有する新しい痩身用食品を開発するこ
とである。
Therefore, the problem to be solved by the present invention is to provide a slimming food containing α-cyclodextrin and γ-linolenic acid as main components, and a new slimming product having a further excellent slimming action. To develop food.

【0008】本発明者は、上記課題を解決するために、
更に鋭意研究を続け、各種数多くの食品用添加剤につい
て実験的研究を続け、遂にある特定の成分を更に第三成
分として配合するときは、これ等三者の相乗作用によっ
て、著しく痩身用効果が上昇することを見出した。
In order to solve the above problems, the present inventor has
Continued diligent research, continued experimental research on various food additives, and finally, when a specific component is further added as the third component, the synergistic action of these three causes a remarkable slimming effect. I found it to rise.

【0009】[0009]

【課題を解決するための手段】本発明者の研究に依る
と、α−サイクロデキストリンとγ−リノレン酸に更に
サポニンを配合するときは、これ等三者の相乗作用によ
り著しく肥満防止効果が大きくなることが見出された。
According to the research conducted by the present inventors, when a saponin is further added to α-cyclodextrin and γ-linolenic acid, the effect of preventing obesity is significantly increased by the synergistic action of these three members. It was found that

【0010】[0010]

【発明の構成】本発明の痩身用食品は、α−サイクロデ
キストリン、γ−リノレン酸及びサポニンとを、好まし
くは上記デキストリン100重量部に対してγ−リノレ
ン酸0.5〜50重量部及び白人参0.3〜6重量部、特
に好ましくはリノレン酸1〜10重量部及びサポニン
0.5〜3.5重量部含有して成るものである。
The slimming food of the present invention comprises α-cyclodextrin, γ-linolenic acid and saponin, preferably 0.5 to 50 parts by weight of γ-linolenic acid and white with 100 parts by weight of the above dextrin. Ginseng 0.3 to 6 parts by weight, particularly preferably 1 to 10 parts by weight of linolenic acid and saponin 0.5 to 3.5 parts by weight are contained.

【0011】本発明に於いて使用されるα−サイクロデ
キストリンとしては、従来から知られているものがいず
れも使用出来る。このα−サイクロデキストリンは、こ
れを単独で使用しても良く、またこれを含有する素材を
使用しても良い。
As the α-cyclodextrin used in the present invention, any conventionally known one can be used. This α-cyclodextrin may be used alone or a material containing it may be used.

【0012】本発明に於いて使用されるγ−リノレン酸
としてもこれを単独で使用しても良く、またこれを含有
する成分乃至物質たとえば月見草油等を使用しても良
い。
The γ-linolenic acid used in the present invention may be used alone, or a component or substance containing the same such as evening primrose oil may be used.

【0013】本発明に於いて使用するサポニンとして
は、従来からサポニンとして知られているものが使用さ
れ、通常植物に分布する配糖体の一群でサポニンと総称
されているものが含まれる。特に好ましくは大豆サポニ
ンである。
As the saponins used in the present invention, those conventionally known as saponins are used, and those generally referred to as saponins in a group of glycosides normally distributed in plants are included. Soybean saponin is particularly preferable.

【0014】本発明に於いては上記3種類の成分を併用
するものであって、これ等三者の相乗作用により、著し
く優れた肥満防止乃至体重増加防止効果を発揮する。こ
の相乗作用は特にα−サイクロデキストリン100重量
部に対しγ−リノレン酸0.5〜50重量部特に好まし
くは1〜40重量部、サポニン0.3〜6重量部特に好
ましくは0.5〜3.5重量部の割合で発揮される。
In the present invention, the above-mentioned three kinds of components are used in combination, and the synergistic action of these three components exerts a remarkably excellent obesity-preventing effect or weight-gain preventing effect. This synergistic action is particularly 0.5 to 50 parts by weight of γ-linolenic acid, particularly preferably 1 to 40 parts by weight, and saponin 0.3 to 6 parts by weight, particularly preferably 0.5 to 3 parts by weight, relative to 100 parts by weight of α-cyclodextrin. Delivered at a rate of 0.5 parts by weight.

【0015】本発明に於いては、更にクロロフィル、杜
仲葉エキス、有胞子状乳酸菌、活性ペプチドの一種、又
は二種以上を配合する場合には、上記サポニン添加に基
づく相乗作用を更に一段と向上せしめることが出来る。
In the present invention, when chlorophyll, eucommia leaf extract, spore-shaped lactic acid bacterium, or one or more active peptides are blended, the synergistic action due to the addition of the saponin is further improved. You can

【0016】クロロフィル自体は良く知られたものであ
って、葉緑素の1種であり、またピロール化合物の一種
である。クロロフィルにはa,b,c,d,e及びバク
テリオクロロフィル、バクテリオピリジンがある。本発
明では一般にクロロフィルと総称されている上記各化合
物の少なくとも1種以上の混合物が有効に使用される。
Chlorophyll itself is well known and is a kind of chlorophyll and a kind of pyrrole compound. Chlorophyll includes a, b, c, d, e and bacteriochlorophyll and bacteriopyridine. In the present invention, a mixture of at least one of the above-mentioned compounds generally called chlorophyll is effectively used.

【0017】又、更にクロロフィルとしてはクロロフィ
ル蛋白質と称される、クロロフィルと蛋白質が結合した
ものも使用することが出来る。
Further, as the chlorophyll, a chlorophyll protein called a chlorophyll protein in which chlorophyll and a protein are bound can be used.

【0018】本発明に於いて使用される杜仲葉エキス、
及び有胞子状乳酸菌自体も又良く知られた食品添加物で
あり、本発明に於いては、これ等従来から使用されて来
たものがいずれも使用される。
Tochu leaf extract used in the present invention,
Also, spore-shaped lactic acid bacterium itself is a well-known food additive, and any of those conventionally used can be used in the present invention.

【0019】特に本発明に於いてはクロロフィルが上記
相乗作用増進に対し効果が大きい。
Particularly in the present invention, chlorophyll has a great effect on the promotion of the above synergistic effect.

【0020】これ等クロロフィル、杜仲葉エキス、及び
有胞子状乳酸菌の使用量はα−サイクロデキストリン1
00重量部に対し、通常0〜5好ましくは1〜3重量部
である。
The amounts of chlorophyll, Tochu leaf extract, and spore-like lactic acid bacteria used are α-cyclodextrin 1
It is usually 0 to 5 parts by weight, preferably 1 to 3 parts by weight, based on 00 parts by weight.

【0021】本発明に於いては、食品または食品添加材
に上記三成分を含有させれば良く、または必要に応じ各
種公知の添加材と共に適当な形状、たとえば錠剤、丸
剤、顆粒状に成型しても良い。この際の食品添加材とし
ては、各種のものが使用出来、小麦粉、食物繊維素、大
豆粉、乳糖、ブドウ糖、澱粉等を具体例として挙げるこ
とが出来る。
In the present invention, the food or food additive may contain the above three components, or may be molded into a suitable shape, such as tablets, pills, or granules, together with various known additives as necessary. You may. In this case, various food additives can be used, and specific examples include wheat flour, dietary fiber, soybean powder, lactose, glucose, starch and the like.

【0022】以下に実験例と本発明の具体例たる実施例
を示す。
Experimental examples and practical examples of the present invention are shown below.

【0023】[0023]

【実験例】成人で健康な女子(年齢21〜25才)15
名をパネラーとして下記のパネルテストを行った。即ち
パネラーを5名づつに5群にわけ、下記の組成物を1日
3回(朝、昼、晩)0.015g/kgの割合で摂取し
てもらい、通常の一定の食事を一定量摂取してもらっ
て、60日後の変化を調べた。変化は尻周り、太もも周
り、体重、外観の4つの項目について行い、各群の平均
値で示した。その評価は組成物摂取前の各項目を基準と
し、それより大きくなった場合を+で、また少なくなっ
た場合を−で表した。その結果を表1に示す。但し表1
の群6はコントロールである。
[Experimental example] Adult healthy girl (age 21-25) 15
The following panel tests were conducted with the name as a panelist. That is, the panelists were divided into 5 groups of 5 people each, and the following composition was ingested three times a day (morning, noon, and evening) at a rate of 0.015 g / kg, and a regular constant meal was ingested in a fixed amount. I was asked to examine the change after 60 days. The change was carried out for four items of hip circumference, thigh circumference, body weight, and appearance, and the average value of each group was shown. The evaluation was based on each item before the composition was ingested, and when it was larger than that, it was represented by +, and when it was smaller, it was represented by −. The results are shown in Table 1. However, Table 1
Group 6 of is a control.

【0024】[0024]

【表1】 [Table 1]

【0025】 組成物1 α−サイクロデキストリンと γ−リノレン酸との混合物(10:1重量比)・・・・・100 重量部 小麦粉・・・・・・・・・・・・・・・・・・・・・・・500 重量部Composition 1 Mixture of α-cyclodextrin and γ-linolenic acid (10: 1 weight ratio) ··· 100 parts by weight wheat flour ··· ..... 500 parts by weight

【0026】 組成物2 上記混合物・・・・・・・・・・・・・・・・・・・・・ 0 重量部 小麦粉・・・・・・・・・・・・・・・・・・・・・・・500 重量部 サポニン・・・・・・・・・・・・・・・・・・・・・・・ 4.0重量 部Composition 2 The above mixture: 0 parts by weight wheat flour: 500 parts by weight saponin 4.0 parts by weight

【0027】 組成物3 上記混合物・・・・・・・・・・・・・・・・・・・・・ 96.0重量部 サポニン・・・・・・・・・・・・・・・・・・・・・・・ 4.0重量 部 小麦粉・・・・・・・・・・・・・・・・・・・・・・・500 重量部Composition 3 The above mixture: 96.0 parts by weight saponin: ...・ ・ ・ 4.0 parts by weight Wheat flour ・ ・ ・ ・ ・ ・ ・ ・ 500 parts by weight

【0028】 組成物4 上記混合物・・・・・・・・・・・・・・・・・・・・・ 98.0重量部 サポニン・・・・・・・・・・・・・・・・・・・・・・・ 2.0重量 部 小麦粉・・・・・・・・・・・・・・・・・・・・・・・500 重量部Composition 4 The above mixture: 98.0 parts by weight Saponin: ...・ ・ ・ ・ ・ ・ ・ ・ 2.0 parts by weight Wheat flour ・ ・ ・ ・ ・ ・ ・ ・ ・ 500 parts by weight

【0029】 組成物5 上記混合物・・・・・・・・・・・・・・・・・・・・・ 99.5重量部 サポニン・・・・・・・・・・・・・・・・・・・・・・・ 0.5重量 部 小麦粉・・・・・・・・・・・・・・・・・・・・・・・500 重量部Composition 5 The above mixture ... 99.5 parts by weight saponin .... ... 0.5 parts by weight wheat flour ... 500 parts by weight

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】α−サイクロデキストリン、γ−リノレン
酸及びサポニンとを含有して成る痩身用食品。
1. A slimming food comprising α-cyclodextrin, γ-linolenic acid and saponin.
【請求項2】α−サイクロデキストリン100重量部に
対して、γ−リノレン酸が0.5〜10重量部及び上記
サポニンが0.3〜6重量部の割合で含有されて成る請
求項1に記載の痩身用食品。
2. The composition according to claim 1, wherein 0.5 to 10 parts by weight of γ-linolenic acid and 0.3 to 6 parts by weight of the saponin are contained in 100 parts by weight of α-cyclodextrin. The slimming food described.
JP5164024A 1993-06-07 1993-06-07 Slimming food Expired - Fee Related JP2510943B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5164024A JP2510943B2 (en) 1993-06-07 1993-06-07 Slimming food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5164024A JP2510943B2 (en) 1993-06-07 1993-06-07 Slimming food

Publications (2)

Publication Number Publication Date
JPH06343419A true JPH06343419A (en) 1994-12-20
JP2510943B2 JP2510943B2 (en) 1996-06-26

Family

ID=15785349

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5164024A Expired - Fee Related JP2510943B2 (en) 1993-06-07 1993-06-07 Slimming food

Country Status (1)

Country Link
JP (1) JP2510943B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999010008A1 (en) * 1997-08-29 1999-03-04 Aquila Biopharmaceuticals, Inc. Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
EP2138190A2 (en) 2002-08-19 2009-12-30 Art Jen Complexus Inc. Compositions comprising dietary fat complexer and methods for their use
US9446111B2 (en) 2009-04-29 2016-09-20 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US10111916B2 (en) 2003-12-05 2018-10-30 Ganeden Biotech, Inc. Compositions comprising Bacillus coagulans spores and whey
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999010008A1 (en) * 1997-08-29 1999-03-04 Aquila Biopharmaceuticals, Inc. Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
EP2138190A2 (en) 2002-08-19 2009-12-30 Art Jen Complexus Inc. Compositions comprising dietary fat complexer and methods for their use
US8101201B2 (en) * 2002-08-19 2012-01-24 ArtJen Complexus, Inc. Compositions comprising dietary fat complexer and methods for their use
JP2013177448A (en) * 2002-08-19 2013-09-09 Soho Flordis Internatl Pty Ltd Composition comprising dietary fat complexer and its use method
US8586076B2 (en) 2002-08-19 2013-11-19 Soho Flordis International Pty Ltd Compositions comprising dietary fat complexer and methods for their use
US9326539B2 (en) 2002-08-19 2016-05-03 Soho Flordis International Pty Ltd. Compositions comprising dietary fat complexers and methods for their use
US10111916B2 (en) 2003-12-05 2018-10-30 Ganeden Biotech, Inc. Compositions comprising Bacillus coagulans spores and whey
US9446111B2 (en) 2009-04-29 2016-09-20 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US9757442B2 (en) 2009-04-29 2017-09-12 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US11351206B2 (en) 2011-03-31 2022-06-07 Ganeden Biotech, Inc. Probiotic sports nutrition compositions

Also Published As

Publication number Publication date
JP2510943B2 (en) 1996-06-26

Similar Documents

Publication Publication Date Title
KR960003608A (en) Healthy food composition that improves diabetes
Gibson et al. Dietary phytate× calcium/zinc millimolar ratios and zinc nutriture in some Ontario preschool children
CA1094451A (en) Method of controlling fecal output and compositions therefor
AU5079600A (en) Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
JP3001880B1 (en) Foods containing wheat leaves
JP3396009B2 (en) Low carious nutritional composition
JPS59175410A (en) Cariostatic agent
JPH0833456A (en) Cream containing live lactic acid bacteria used industrial production of confectionery
JP2510943B2 (en) Slimming food
JP2005013211A (en) Lactobacillus-containing food composition
Pereira et al. Failure of massive single oral dose of vitamin A to prevent deficiency
JP3413134B2 (en) Composition for dietary fiber intake
JPS6094912A (en) Agent for reducing neutral fat in body
JP2605208B2 (en) Slimming food
JPS6211072A (en) Fat-reducing food
JPH07115934A (en) Diet food
US20010014368A1 (en) High-protein food of plate form and process for producing the same
JP2000245391A (en) Healthy food
JPH06153860A (en) Flesh-reducing food
Zepplin et al. Dental Caries in the Cotton Rat: XI. The Effect of Feeding a Natural Diet Comparable to a Human Diet
JP6923065B1 (en) Oral solid composition
JP2002068979A (en) Food having reducing action on human serum cholesterol level and agent for preventing or curing hypercholesterolemia
JP7373918B2 (en) Composition for regulating skin gas diffusion
DE2451388A1 (en) METHOD OF DETOXIFYING GLUE IN FOOD
JP3382871B2 (en) healthy food

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080416

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110416

Year of fee payment: 15

LAPS Cancellation because of no payment of annual fees